Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Nabriva Therapeutics AG | 9,100 | reported | 31 Jul 2022 | tx 4+63,500−8,400 |
| Spark Therapeutics, Inc. | 0 | reported | 17 Dec 2019 | tx 16+49,162−190,874 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 31 Jul 2022 | TAX_WITHHOLDING | Nabriva Therapeutics AG | 8,400 | 0.18 USD | |
| 28 Jul 2021 | GRANT_AWARD | Nabriva Therapeutics AG | 17,500 | 0.00 USD | |
| 28 Jul 2021 | GRANT_AWARD | Nabriva Therapeutics AG | 35,500 | 0.00 USD | deriv |
| 02 Jun 2021 | GRANT_AWARD | Nabriva Therapeutics AG | 10,500 | 0.00 USD | deriv |
| 17 Dec 2019 | TENDER | Spark Therapeutics, Inc. | 4,134 | 114.50 USD | |
| 17 Dec 2019 | OTHER | Spark Therapeutics, Inc. | 20,325 | 0.00 USD | deriv |
| 17 Dec 2019 | OTHER | Spark Therapeutics, Inc. | 19,951 | 0.00 USD | deriv |
| 17 Dec 2019 | OTHER | Spark Therapeutics, Inc. | 28,389 | 0.00 USD | deriv |
| 17 Dec 2019 | OTHER | Spark Therapeutics, Inc. | 30,000 | 0.00 USD | deriv |
| 17 Dec 2019 | OTHER | Spark Therapeutics, Inc. | 19,500 | 0.00 USD | deriv |
| 17 Dec 2019 | OTHER | Spark Therapeutics, Inc. | 35,000 | 0.00 USD | deriv |
| 17 Dec 2019 | OTHER | Spark Therapeutics, Inc. | 28,000 | 0.00 USD | deriv |
| 18 Jan 2019 | EXERCISE | Spark Therapeutics, Inc. | 2,000 | — | |
| 18 Jan 2019 | TAX_WITHHOLDING | Spark Therapeutics, Inc. | 621 | 45.08 USD | |
| 18 Jan 2019 | EXERCISE | Spark Therapeutics, Inc. | 2,162 | — | |
| 18 Jan 2019 | TAX_WITHHOLDING | Spark Therapeutics, Inc. | 792 | 45.08 USD | |
| 18 Jan 2019 | EXERCISE | Spark Therapeutics, Inc. | 2,000 | 0.00 USD | deriv |
| 18 Jan 2019 | EXERCISE | Spark Therapeutics, Inc. | 2,162 | 0.00 USD | deriv |
| 15 Jan 2019 | GRANT_AWARD | Spark Therapeutics, Inc. | 35,000 | 0.00 USD | deriv |
| 15 Jan 2019 | GRANT_AWARD | Spark Therapeutics, Inc. | 10,000 | 0.00 USD | deriv |